Main Story
-
REAL Jet and Crypto.com Give Customers a New Way to Pay for Private Flights
Customers Can Now Use Crypto.com Pay™ to fly REAL Jet NEW YORK, Aug. 5, 2026 /PRNewswire/ — REAL Jet, a REAL SLX company, has officially launched Crypto.com Pay, allowing customers to use the digital payment solution on the company’s charter booking platform. With it, REAL Jet becomes the first private aviation company to accept Crypto.com…
Products
-
AccuSure AS9 Fully Automatic Digital Blood Pressure Monitor With Large Display
Original price was: ₹1,733.00.₹998.00Current price is: ₹998.00. -
AGEasy Max Group Fully Automatic One Touch Digital Blood Pressure Monitoring Device
Original price was: ₹1,405.00.₹949.00Current price is: ₹949.00. -
Automatic Digital Blood Pressure Monitor for Upper Arm, Large LCD Display
Original price was: ₹2,399.00.₹448.00Current price is: ₹448.00. -
Beurer German Engineering P0 13 Kid’s Pulse Oximeter I Fingertip Home Pulse Oximeter
Original price was: ₹2,745.00.₹1,538.00Current price is: ₹1,538.00. -
BPL Medical Technologies Bluetooth Enabled Arm Type Blood Pressure Monitor
Original price was: ₹6,563.00.₹5,199.00Current price is: ₹5,199.00.
Automobile
Tech
Entertainment
Health
-
GuideAI Health Corp. Announces Frankfurt Stock Exchange Symbol: ZN0
BOSTON, Aug. 14, 2026 (GLOBE NEWSWIRE) — GuideAI Health Corp. (“GuideAI” or the “Company“) (Cboe CA: GDAI) (FSE: ZN0) is pleased to announce its common shares are now posted on the Frankfurt Stock Exchange (“FSE”) under the symbol “ZN0”, WKN: A42EHA, and ISIN: CA CA40173G1019. Source: GuideAI Health Corp. Announces Frankfurt Stock Exchange Symbol: ZN0
-
BeyondSpring Reports Second-Quarter 2026 Financial Results and Provides Corporate Update
ASCO 2026 Data Demonstrate Long-term Survival Benefit of Plinabulin/Docetaxel and Pembrolizumab in Metastatic NSCLC Following Progression on First-Line Immune Checkpoint Inhibitor (ICI) Therapy Source: BeyondSpring Reports Second-Quarter 2026 Financial Results and Provides Corporate Update
-
Avicanna Reports Q2 2026 Financial Results
Gross margin improves to 57%, supported by 48% quarterly growth in proprietary product salesQUIX™ rapid-onset portfolio prepared for Q3 launch with more than 35 commercial listings secured Source: Avicanna Reports Q2 2026 Financial Results
-
More Cancer Patients Are Opting to Preserve Their Tumors
New Tumor-Preservation Service Opens in Arizona, Giving Patients the Chance to Preserve Tumor Tissue for Potential Personalized Dendritic Cell Therapy Source: More Cancer Patients Are Opting to Preserve Their Tumors
-
Axtria to Build Industry’s Largest Pharma-Specific AI Engineering Team, Scaling to 1,000 by December 2026
NEW DELHI, Aug. 13, 2026 /PRNewswire/ — Axtria Inc., a global leader in AI-first data analytics solutions for the life sciences industry, today announced plans to expand its Forward Deployed Engineering (FDE) organization to 1,000 engineers by December 2026, creating the industry’s largest pharma-specific AI engineering team. The expansion represents one of Axtria’s largest investments in AI…
-
Belite Bio Reports Unaudited Second Quarter 2026 Financial Results and Provides a Corporate Update
SAN DIEGO, Aug. 12, 2026 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio®” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced its financial results for the second quarter ended June 30, 2026, and provided a business…
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.
